Silent beginning: Early silencing of the MED1/MBD4 gene in colorectal tumorigenesis

Cancer Biology and Therapy

Volumn 8, Issue 2, 2009, Pages 192-193

  Lucci Cordisco, Emanuela ^a   Neri, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Colorectal cancer; Epigenetics; MBD4; MED1; Ovarian cancer; Promoter hypermethylation; Tumorigenesis

Indexed keywords

ALKYLATING AGENT; APC; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DEATH ASSOCIATED PROTEIN KINASE; FLUOROURACIL; HISTONE DEACETYLASE; METHYL CPG BINDING PROTEIN; PROTEIN MLH1;

CARCINOGENESIS; COLORECTAL CANCER; DNA HYPERMETHYLATION; DNA METHYLATION; EPIGENETICS; EXCISION REPAIR; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE INACTIVATION; GENE SILENCING; HUMAN; MICROSATELLITE INSTABILITY; NONHUMAN; NOTE; PROMOTER REGION; TRANSCRIPTION REGULATION;

EID: 58749114744     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.2.7647     Document Type: Note

References (23)

1. Gopalakrishnan S, Van Emburgh BO, Robertson KD. DNA methylation in development and human disease. Mutat Res 2008; 647:30-8.
2. United States Cancer Statistics: 2003 Incidence and Mortality (preliminary data). US Cancer Statistics Working Group 2006.
3. American Cancer Society. Cancer Facts and Figures 2007; available at http//www.cancer.org.
4. Agrawal A, Murphy RF and Agrawal DK. DNA methylation in breast and colorectal cancers. Modern Pathology 2007; 20:711-21.
5. Barton CA, Hacker NF, Clark SJ, O'Brien PM. DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment. Gynecol Oncol 2008; 109:129-39.
6. Howard HJ, Frolov A, Tzeng CD, Stewart A, Midzak A, Majmundar A, Godwin AK, Heslin MJ, Bellacosa A, Arnletti JP. Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancer. Cancer Biol Ther 2008; 8:94-100.
7. Petronzelli F, Riccio A, Markham GD, Seeholzer SH, Stoerker J, Genuardi M, Yeung AT, Matsumoto Y, Bellacosa A. Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase. J Biol Chem 2000; 275:32422-9.
8. Kondo E, Gu Z, Horii A, Fukushige S. The thymine DNA glycosylase MBD4 represses transcription and is associated with methylated p16(INK4a) and hMLH1 genes. Mol Cell Biol 2005; 25:4388-96.
9. Majumder S, Kutay H, Datta J, Summers D, Jacob ST, Ghoshal K. Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins. J Cell Biochem 2006; 97:1300-16.
10. Cortellino S, Turner D, Masciullo V, Schepis F, Albino D, Daniel R, Skalka AM, Meropol NJ, Alberti C, Larue L, et al. The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity. Proc Natl Acad Sci USA 2003; 100:15071-6.
11. Turner DP, Cortellino S, Schupp JE, Caretti E, Loh T, Kinsella TJ, Bellacosa A. The DNA N-glycosylase MED1 exhibits preference for halogenated pyrimidines and is involved in the cytotoxicity of 5-iododeoxyuridine. Cancer Res 2006; 66:7686-93.
12. Sansom OJ, Zabkiewicz J, Bishop SM, Guy J, Bird A, Clarke AR. MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine. Oncogene 2003; 22:7130-6.
13. Screaton RA, Kiessling S, Sansom OJ, Millar CB, Maddison K, Bird A, Clarke AR, Frisch SM. Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis. Proc Natl Acad Sci USA 2003; 100:5211-6.
14. Abdel-Rahman WM, Knuutila S, Peltomäki P, Harrison DJ, Bader SA. Truncation of MBD4 predisposes to reciprocal chromosomal translocations and alters the response to therapeutic agents in colon cancer cells. DNA Repair 2008; 7:321-8.
15. Millar CB, Guy J, Sansom OJ, Selfridge J, MacDougall E, Hendrich B, Keightley PD, Bishop SM, Clarke AR, Bird A. Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science 2002; 297:403-5.
16. Wong E, Yang K, Kuraguchi M, Werling U, Avdievich E, Fan K, Fazzari M, Jin B, Brown AM, Lipkin M, et al. Mbd4 inactivation increases C → T transition mutations and promotes gastrointestinal tumor formation. Proc Natl Acad Sci USA 2002; 99:14937-42.
17. Bader S, Walker M, Hendrich B, Bird A, Bird C, Hooper M, Wyllie A. Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. Oncogene 1999; 18:8044-7.
18. Bader S, Walker M, Harrison D. Most microsatellite unstable sporadic colorectal carcinomas carry MBD4 mutations. Br J Cancer 2000; 83:1646-9.
19. Riccio A, Aaltonen LA, Godwin AK, Loukola A, Percesepe A, Salovaara R, Masciullo V, Genuardi M, Paravatou-Petsotas M, Bassi DE. Ruggeri BA, Klein-Szanto AJ, Testa JR, Neri G, Bellacosa A. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet 1999; 23:266-8.
20. Shin MC, Lee SJ, Choi JE, Cha SI, Kim CH, Lee WK, Kam S, Kang YM, Jung TH, Park JY. Glu346Lys polymorphism in the methyl-CpG binding domain 4 gene and the risk of primary lung cancer. Jpn J Clin Oncol 2006; 36:483-8.
21. Shibata D, Peinado MA, Ionov Y, Malkhosyan S, Perucho M. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nat Genet 1994; 6:273-81.
22. Bellacosa A. Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Cell Death Differ 2001; 8:1076-92.
23. Parsons BL. MED1: a central molecule for maintenance of genome integrity and response to DNA damage. Proc Natl Acad Sci USA 2003; 100:14601-2.